Catecholaminergic polymorphic ventricular tachycardia primary prevention
Editor-In-Chief: C. Michael Gibson, M.S., M.D. [1]; Associate Editor(s)-in-Chief: Mounika Reddy Vadiyala, M.B.B.S.[2]
Overview
Overview
There are no established measures for the primary prevention of catecholaminergic polymorphic ventricular tachycardia. However, episodes of syncope and sudden cardiac arrest can be prevented with lifestyle modifications, holter monitoring and compliance with medical therapy.
Primary Prevention
Primary Prevention
There are no established measures for the primary prevention of catecholaminergic polymorphic ventricular tachycardia.
However, there are preventive measures for episodes of catecholaminergic polymorphic ventricular tachycardia, which include:
- Lifestyle modifications:[1]
- Limit or avoid competitive sports
- Limit or avoid strenuous exercises
- Limit exposure to stressful environments
- Holter monitoring: It helps in keeping the heart-rate within a safe range during physical activity.
- Compliance with medical therapy.
- Follow-up visits with a cardiologist every six to twelve months to monitor the efficacy of therapy.
References
References
- ↑ Priori, Silvia G.; Blomström-Lundqvist, Carina; Mazzanti, Andrea; Blom, Nico; Borggrefe, Martin; Camm, John; Elliott, Perry Mark; Fitzsimons, Donna; Hatala, Robert; Hindricks, Gerhard; Kirchhof, Paulus; Kjeldsen, Keld; Kuck, Karl-Heinz; Hernandez-Madrid, Antonio; Nikolaou, Nikolaos; Norekvål, Tone M.; Spaulding, Christian; Van Veldhuisen, Dirk J. (2015). “2015 ESC Guidelines for the management of patients with ventricular arrhythmias and the prevention of sudden cardiac death”. European Heart Journal. 36 (41): 2793–2867. doi:10.1093/eurheartj/ehv316. ISSN 0195-668X.
Looking for the patient version?
© 2026 MyEClinic – IFTM Institut für Telematik in der Medizin GmbH
